October 2018 FDA Recall Drug by Boehringer Ingelheim Pharmaceuticals, Inc.
D-0128-2019 - Failed Dissolution Specifications

This Class II drug recall was voluntarily initiated by Boehringer Ingelheim Pharmaceuticals, Inc. on October 22, 2018 for the product Drug. The FDA reported the reason for recall as failed dissolution specifications. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0128-2019

Reason for Recall
Failed Dissolution Specifications: OOS resultsduring routine stability testing
Initiated
10-22-2018
Reported
11-07-2018
Quantity
1,380 100-count bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Boehringer Ingelheim Pharmaceuticals, Inc.
Distributed nationwide in the USA and Puerto Rico
Catapres .2 (clonidine hydrochloride, USP) 0.2mg, 100-count bottles, Rx only, Dist. by: Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT 06877 USA. Made in Germany. NDC 0597-0007-01

Batch or Lot Expiration Information

Lot# Lot: 757739, EXP 9/2020